MTA2 and viral infectious disease: This is in part due to the rise of novel pathogens, as exemplified by the COVID-19 pandemic during which pathogenic variants in both novel and known PID genes involved in the host immune response to viral infections have been associated with more severe forms of infection caused by the SARS-CoV-2 virus [69, 70].